| Primary |
| Hypersensitivity |
10.4% |
| Pruritus |
10.4% |
| Urticaria |
10.4% |
| Chronic Obstructive Pulmonary Disease |
6.3% |
| Drug Eruption |
6.3% |
| Grand Mal Convulsion |
6.3% |
| Supraventricular Tachycardia |
6.3% |
| Thrombosis Prophylaxis |
6.3% |
| Dermatitis Allergic |
4.2% |
| Epilepsy |
4.2% |
| Hypercholesterolaemia |
4.2% |
| Mitral Valve Incompetence |
4.2% |
| Nasopharyngitis |
4.2% |
| Swollen Tongue |
4.2% |
| Allergy Test |
2.1% |
| Anaemia Haemolytic Autoimmune |
2.1% |
| Arthritis |
2.1% |
| Asthma |
2.1% |
| Attention Deficit/hyperactivity Disorder |
2.1% |
| Breast Cancer |
2.1% |
|
| Yellow Skin |
10.3% |
| Circulatory Collapse |
6.9% |
| Drug Prescribing Error |
6.9% |
| Epilepsy |
6.9% |
| Maternal Drugs Affecting Foetus |
6.9% |
| Peripheral Circulatory Failure |
6.9% |
| Stomatitis |
6.9% |
| Toxic Epidermal Necrolysis |
6.9% |
| Anaphylactic Shock |
3.4% |
| Confusional State |
3.4% |
| Convulsion |
3.4% |
| Drug Exposure During Pregnancy |
3.4% |
| Electrocardiogram Qt Prolonged |
3.4% |
| Fatigue |
3.4% |
| Fear |
3.4% |
| Fluid Retention |
3.4% |
| Hallucination, Visual |
3.4% |
| Heart Rate Increased |
3.4% |
| Hepatic Function Abnormal |
3.4% |
| Laryngeal Oedema |
3.4% |
|
| Secondary |
| Drug Use For Unknown Indication |
14.9% |
| Chronic Obstructive Pulmonary Disease |
6.3% |
| Product Used For Unknown Indication |
6.1% |
| Thrombosis Prophylaxis |
6.1% |
| Dermatitis |
5.8% |
| Grand Mal Convulsion |
5.8% |
| Coronary Artery Disease |
5.5% |
| Epilepsy |
5.5% |
| Sleep Disorder |
5.2% |
| Premedication |
5.0% |
| Nausea |
4.1% |
| Pruritus |
4.1% |
| Rash |
4.1% |
| Supraventricular Tachycardia |
3.9% |
| Hiv Infection |
3.3% |
| Pain |
3.3% |
| Vomiting |
3.3% |
| Tachycardia Paroxysmal |
3.0% |
| Urticaria |
2.5% |
| Cystitis |
2.2% |
|
| Toxic Epidermal Necrolysis |
27.1% |
| Adverse Drug Reaction |
10.4% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
8.3% |
| Convulsion |
6.3% |
| Saccadic Eye Movement |
6.3% |
| Laryngeal Oedema |
4.2% |
| Metabolic Acidosis |
4.2% |
| Nausea |
4.2% |
| Pulse Absent |
4.2% |
| Stevens-johnson Syndrome |
4.2% |
| Acidosis |
2.1% |
| Blood Pressure Increased |
2.1% |
| Death |
2.1% |
| Diplopia |
2.1% |
| Eczema |
2.1% |
| Electrocardiogram Qt Prolonged |
2.1% |
| Face Oedema |
2.1% |
| Fluid Retention |
2.1% |
| General Physical Health Deterioration |
2.1% |
| Hallucination, Visual |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
17.4% |
| Drug Use For Unknown Indication |
16.2% |
| Premedication |
14.6% |
| Prophylaxis |
10.3% |
| Diffuse Large B-cell Lymphoma |
4.7% |
| Breast Cancer |
4.2% |
| Infection |
3.9% |
| Malignant Lymphoid Neoplasm |
3.5% |
| Pain |
3.2% |
| Hypertension |
2.9% |
| Infection Prophylaxis |
2.8% |
| Peripheral T-cell Lymphoma Unspecified |
2.7% |
| Constipation |
2.1% |
| Nausea |
2.1% |
| Non-small Cell Lung Cancer |
2.0% |
| B-cell Lymphoma |
1.9% |
| Chronic Lymphocytic Leukaemia |
1.7% |
| Non-hodgkin's Lymphoma |
1.6% |
| Acute Leukaemia |
1.2% |
| Hypersensitivity |
1.1% |
|
| Pyrexia |
12.1% |
| Death |
7.0% |
| Pulmonary Embolism |
6.5% |
| Disseminated Intravascular Coagulation |
6.0% |
| Leukopenia |
6.0% |
| Sepsis |
6.0% |
| Pneumonia |
5.6% |
| Febrile Neutropenia |
5.1% |
| Rash |
5.1% |
| Tremor |
4.7% |
| Back Pain |
4.2% |
| Neutropenia |
3.7% |
| Pancytopenia |
3.7% |
| Thrombocytopenia |
3.7% |
| Urinary Incontinence |
3.7% |
| Vomiting |
3.7% |
| Circulatory Collapse |
3.3% |
| Ileus |
3.3% |
| Paraesthesia |
3.3% |
| Renal Failure Acute |
3.3% |
|
